Retraction: JARID1B promotes metastasis and epithelial-mesenchymal transition via PTEN/AKT signaling in hepatocellular carcinoma cells.
APA
Tang B, Qi G, et al. (2026). Retraction: JARID1B promotes metastasis and epithelial-mesenchymal transition via PTEN/AKT signaling in hepatocellular carcinoma cells.. Oncotarget, 17(1), 185-186. https://doi.org/10.18632/oncotarget.28847
MLA
Tang B, et al.. "Retraction: JARID1B promotes metastasis and epithelial-mesenchymal transition via PTEN/AKT signaling in hepatocellular carcinoma cells.." Oncotarget, vol. 17, no. 1, 2026, pp. 185-186.
PMID
42024885
같은 제1저자의 인용 많은 논문 (5)
- Identification and validation of NETs-related biomarkers in hepatocellular carcinoma through bioinformatics analysis and machine learning algorithms.
- Interventional therapy for hepatocellular carcinoma in the immunotherapy era: From mechanism exploration to materials innovation.
- Transarterial Chemoembolization Modulates the Exosomal miR-32-5p/cGAS-STING Axis Mediated Macrophage Ferroptosis, Triggers Immune Remodeling, and Enhances Anti-PD-1/L1 Efficacy in HCC.
- Immune checkpoint inhibitor-induced vitiligo: A large-scale real world pharmacovigilance study.
- Pharmacovigilance Insights Into Immune Checkpoint Inhibitor-Induced Risk of Paraneoplastic Syndrome: A Large-Scale Real World Study.